132 related articles for article (PubMed ID: 36122532)
21. p22-phox-deficient chronic granulomatous disease: reconstitution by retrovirus-mediated expression and identification of a biosynthetic intermediate of gp91-phox.
Porter CD; Parkar MH; Verhoeven AJ; Levinsky RJ; Collins MK; Kinnon C
Blood; 1994 Oct; 84(8):2767-75. PubMed ID: 7919388
[TBL] [Abstract][Full Text] [Related]
22. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
[TBL] [Abstract][Full Text] [Related]
23. Identification of allele-specific p22-phox mutations in a compound heterozygous patient with chronic granulomatous disease by mismatch PCR and restriction enzyme analysis.
Hossle JP; de Boer M; Seger RA; Roos D
Hum Genet; 1994 Apr; 93(4):437-42. PubMed ID: 8168815
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of p22phox is mediated by phospholipase D-dependent and -independent mechanisms. Correlation of NADPH oxidase activity and p22phox phosphorylation.
Regier DS; Greene DG; Sergeant S; Jesaitis AJ; McPhail LC
J Biol Chem; 2000 Sep; 275(37):28406-12. PubMed ID: 10893420
[TBL] [Abstract][Full Text] [Related]
26. Interpretation of Dihydrorhodamine-1,2,3 Flow Cytometry in Chronic Granulomatous Disease: an Atypical Exemplar.
Donko A; Kuhns DB; Cousin MA; Smith MJ; Sacco KA; Klee EW; Joshi AY; Gavrilova RH; Holland SM; Leto TL; Abraham RS
J Clin Immunol; 2022 Jul; 42(5):986-999. PubMed ID: 35344128
[TBL] [Abstract][Full Text] [Related]
27. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
[TBL] [Abstract][Full Text] [Related]
28. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
[TBL] [Abstract][Full Text] [Related]
29. Mutation of the Cyba gene encoding p22phox causes vestibular and immune defects in mice.
Nakano Y; Longo-Guess CM; Bergstrom DE; Nauseef WM; Jones SM; Bánfi B
J Clin Invest; 2008 Mar; 118(3):1176-85. PubMed ID: 18292807
[TBL] [Abstract][Full Text] [Related]
30. PPARδ activation inhibits homocysteine-induced p22(phox) expression in EA.hy926 cells through reactive oxygen species/p38MAPK pathway.
Xiao GF; Xu SH; Chao Y; Xie LD; Xu CS; Wang HJ
Eur J Pharmacol; 2014 Mar; 727():29-34. PubMed ID: 24486703
[TBL] [Abstract][Full Text] [Related]
31. Soluble Regulatory Proteins for Activation of NOX Family NADPH Oxidases.
Sumimoto H; Minakami R; Miyano K
Methods Mol Biol; 2019; 1982():121-137. PubMed ID: 31172470
[TBL] [Abstract][Full Text] [Related]
32. NOX2, p22phox and p47phox are targeted to the nuclear pore complex in ischemic cardiomyocytes colocalizing with local reactive oxygen species.
Hahn NE; Meischl C; Wijnker PJ; Musters RJ; Fornerod M; Janssen HW; Paulus WJ; van Rossum AC; Niessen HW; Krijnen PA
Cell Physiol Biochem; 2011; 27(5):471-8. PubMed ID: 21691064
[TBL] [Abstract][Full Text] [Related]
33. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
[TBL] [Abstract][Full Text] [Related]
34. Protein-Protein Interaction Assay to Analyze NOX4/p22
O'Neill S; Knaus UG
Methods Mol Biol; 2019; 1982():447-458. PubMed ID: 31172488
[TBL] [Abstract][Full Text] [Related]
35. NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells.
Stanicka J; Russell EG; Woolley JF; Cotter TG
J Biol Chem; 2015 Apr; 290(15):9348-61. PubMed ID: 25697362
[TBL] [Abstract][Full Text] [Related]
36. O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase.
Archer SL; Reeve HL; Michelakis E; Puttagunta L; Waite R; Nelson DP; Dinauer MC; Weir EK
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7944-9. PubMed ID: 10393927
[TBL] [Abstract][Full Text] [Related]
37. Biosynthesis of the phagocyte NADPH oxidase cytochrome b558. Role of heme incorporation and heterodimer formation in maturation and stability of gp91phox and p22phox subunits.
Yu L; Zhen L; Dinauer MC
J Biol Chem; 1997 Oct; 272(43):27288-94. PubMed ID: 9341176
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
Teimourian S; de Boer M; Roos D
J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
[TBL] [Abstract][Full Text] [Related]
39. Cell-Free NADPH Oxidase Activation Assays: A Triumph of Reductionism.
Pick E
Methods Mol Biol; 2020; 2087():325-411. PubMed ID: 31729001
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells.
Bayraktutan U; Blayney L; Shah AM
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1903-11. PubMed ID: 10938010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
